BioNTech SE

Yahoo Finance • 4 days ago

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

Trastuzumab pamirtecan, an investigational HER2-targeted antibody-drug conjugate, met the primary efficacy endpoint in a Phase 2 cohort of heavily pre-treated patients with HER2-expressing, recurrent endometrial cancer, an area of high unm... Full story

Yahoo Finance • 4 days ago

BioNTechs und DualityBios Antikörper-Wirkstoff-Konjugat-Kandidat Trastuzumab Pamirtecan zeigte klinisch relevante Wirksamkeit bei Patientinnen mit rezidivierendem HER2-exprimierendem Gebärmutterkrebs

Trastuzumab Pamirtecan, ein innovativer gegen HER2 gerichteter Antikörper-Wirkstoff-Konjugat-Kandidat, erreichte den primären Wirksamkeitsendpunkt in einer Phase-2-Kohorte bei stark vorbehandelten Patientinnen mit HER2-exprimierenden rezid... Full story

Yahoo Finance • 6 days ago

Report on COVID vaccine benefits being delayed at CDC: WaPo

[CDC Centers for Disease Control and Prevention] The acting director of the Centers for Disease Control and Prevention, Jay Bhattacharya, has delayed the publication of a CDC report indicating that COVID vaccines cut the risk of ER visits... Full story

Yahoo Finance • 8 days ago

Messenger RNA (mRNA) Market Projected to Reach $20.99 Billion by 2035 - Moderna, Pfizer, and Others Propel mRNA Expansion into New Therapeutic Areas

Company Logo Messenger RNA MarketMessenger RNA Market·GlobeNewswire Inc. Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Messenger RNA Market - A Global and Regional Analysis: Application and Regional Analysis - Analysis and Forecast, 20... Full story

Yahoo Finance • 15 days ago

BMO Capital Cuts PT on BioNTech SE (BNTX) to $128 From $143 – Here’s Why

BioNTech SE (NASDAQ:BNTX) is one of the best high growth healthcare stocks to buy now. On March 11, BMO Capital cut the price target on BioNTech SE (NASDAQ:BNTX) to $128 from $143 and reiterated an Outperform rating on the shares. The firm... Full story

Yahoo Finance • 16 days ago

Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Recurrent Head and Neck Cancer Squamous Cell Carcinoma Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers comprehensive insights on market size, reg... Full story

Yahoo Finance • 22 days ago

BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer

Presentations showcase progress in BioNTech’s late-stage lung cancer programs, reinforcing the potential of the Company’s differentiated portfolio spanning immunomodulators, antibody-drug conjugates, mRNA cancer immunotherapies, and their... Full story

Yahoo Finance • 22 days ago

BioNTech auf dem ELCC-Kongress 2026: Neue klinische Daten unterstreichen das Potenzial des differenzierten, spätklinischen Portfolios bei Lungenkrebs

Präsentationen zeigen Fortschritte in BioNTechs spätklinischen Programmen im Bereich Lungenkrebs und unterstreichen das Potenzial des differenzierten Unternehmensportfolios, welches Immunmodulatoren, Antikörper-Wirkstoff-Konjugate und mRNA... Full story

Yahoo Finance • 25 days ago

Trump administration reportedly shortlisting CDC nominees

[Centers for disease control and prevention sign] sshepard Two physicians with somewhat contrasting views on vaccines are among the potential candidates the Trump administration is considering as its pick to lead the U.S. Centers for Dise... Full story

Yahoo Finance • 27 days ago

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

European equities traded in the US as American depositary receipts were down sharply late Thursday m PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers

When veterinarians told Sydney tech entrepreneur Paul Conyngham that his rescue dog Rosie had months to live, he didn't accept the prognosis. Instead, the data scientist and machine learning engineer — with 17 years in the field but no bac... Full story

Yahoo Finance • last month

European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading

European equities traded in the US as American depositary receipts edged lower late Wednesday mornin PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

BioNTech co-founders step down to launch new mRNA venture

The co-founders of BioNTech will leave the company to launch a new mRNA-focused entity, amid mounting losses for the vaccine specialist. Uğur Şahin and Özlem Türeci established BioNTech in 2008 – the husband-and-wife team currently serve... Full story

Yahoo Finance • last month

US Stock Market Today: S&P 500 Futures Edge Lower As Inflation Jitters Linger

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. The Morning Bull - US Market Morning Update Wednesday, Mar, 11 202... Full story

Yahoo Finance • last month

Biontech outlines €2B–€2.3B revenue target for 2026 while advancing late-stage oncology pipeline and leadership transition

Earnings Call Insights: BioNTech SE (BNTX) Q4 2025 MANAGEMENT VIEW * CEO Ugur Sahin highlighted that BioNTech maintained its leadership in the COVID vaccine market, launching a variant-adapted vaccine in partnership with Pfizer, now di... Full story

Yahoo Finance • last month

Equities Mostly Fall as Oil Prices Pare Losses

US equities closed mostly lower on Tuesday, while oil prices pared losses as traders continued to tr PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • last month

Stock market today: Dow, S&P 500 end lower, oil slides as Wall Street weighs Iran war signals

US stocks ended little changed on Tuesday to cap a volatile trading session as investors weighed President Trump's hint at a swift end to the Iran war, while oil futures trimmed losses. The Dow Jones Industrial Average (^DJI) and S&P 500... Full story

Yahoo Finance • last month

Sector Update: Health Care Stocks Decline Late Afternoon

Health care stocks were lower late Tuesday afternoon, with the NYSE Health Care Index shedding 0.9% PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • last month

Stock market today: Dow, S&P 500, Nasdaq trim gains, oil falls as Wall Street weighs Iran war signals

US stocks trimmed gains on Tuesday as investors weighed President Trump's hint at a swift end to the Iran war, while oil futures trimmed losses. The Dow Jones Industrial Average (^DJI) and S&P 500 (^GSPC) lost earlier gains to hover near... Full story

Yahoo Finance • last month

BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges

This article first appeared on GuruFocus. Total Revenue: EUR2.9 billion for 2025. Cash and Equivalents: EUR17.2 billion at the end of 2025. R&D Expenses: Approximately EUR2.1 billion for 2025. Adjusted Non-IFRS Net Loss: EUR117 million fo... Full story